drugset / Trial / NCT06223048
A Study of AMDX-2011P in Participants With Primary Open Angle Glaucoma
RandomizedParallel-groupSingle-blindDiagnostic
Summary
The purpose of this research study is to assess the ability of AMDX- 2011P to identify amyloid deposits in the retina of participants with Primary Open Angle Glaucoma (POAG).
Timeline
- Start
- 2023-12-07
- Primary completion
- 2024-11
- Completion
- 2025-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AMDX-2011P | Diagnostic / imaging agent | 50 mg | Intravenous |
| Subject | AMDX-2011P | Diagnostic / imaging agent | 100 mg | Intravenous |